Healthcare Shifts: DHA Seeks EHR Input, Rural Health Funding Soars, and Hospitals Halt Drug Pilot
A wave of significant developments is reshaping the U.S. healthcare landscape, from the future of military healthcare technology to a massive investment in rural health infrastructure and a legal victory for hospitals challenging federal drug pricing policies. These events, unfolding on December 29, 2025, signal a period of both innovation and contention within the industry.
Modernizing Military Healthcare: DHA’s MHS GENESIS Strategy
The Defense Health Agency (DHA) is actively seeking input from industry leaders as it develops a strategy for the next generation of its electronic health record (EHR) system, MHS GENESIS. The agency has issued a Request for Information (RFI) to gather feedback on a draft contract strategy and a proposed restructuring of its program office. This new structure aims to distinctly separate technical integration, human-centered design, and product management – a move intended to streamline development and improve the user experience.
According to a DHA statement, the agency is prioritizing a more agile and responsive approach to EHR development. This shift reflects lessons learned from the initial rollout of MHS GENESIS, which faced significant challenges. The RFI represents a critical step in ensuring the next iteration of the system effectively meets the needs of military healthcare professionals and beneficiaries.
$50 Billion Boost for Rural Health Access
In a landmark decision, the Centers for Medicare & Medicaid Services (CMS) announced the distribution of $50 billion in awards to strengthen rural health across all 50 states. States will receive awards averaging $200 million through the Rural Health Transformation Program, with funds earmarked for initiatives focused on modernizing rural health infrastructure and technology.
This substantial investment addresses critical disparities in healthcare access for rural communities. The funding is expected to support projects ranging from telehealth expansion and broadband internet access to upgrades of rural hospitals and clinics. “This program represents a vital lifeline for rural healthcare providers,” one analyst noted. “It will enable them to deliver higher-quality care and address the unique challenges faced by their patients.”
Hospitals Win Injunction Against HHS Drug Pricing Pilot
Hospitals have secured a temporary reprieve from a controversial new drug discount program. A federal judge issued a preliminary injunction halting the implementation of the 340B Rebate Model Pilot Program proposed by the Department of Health and Human Services (HHS). The lawsuit, brought by the American Hospital Association and other healthcare organizations, challenged the program’s structure, which would have required providers to purchase drugs at full price and then seek rebates from pharmaceutical companies.
The judge’s decision prevents HHS from moving forward with the pilot program while the legal challenge proceeds. A senior official from the American Hospital Association stated, “We are pleased with the court’s decision, which protects vulnerable patients and preserves access to critical medications.” The 340B program provides discounted drugs to hospitals that serve a high proportion of low-income patients, and the proposed changes were widely criticized for potentially undermining its effectiveness.
These three developments – the DHA’s EHR strategy, the rural health funding boost, and the hospital’s legal victory – collectively illustrate the dynamic forces shaping the future of healthcare in the United States, highlighting the ongoing efforts to improve access, affordability, and quality of care for all Americans.
